[1]李蕾,李美香,张颖,等.比阿培南治疗儿童重症社区获得性肺炎效果[J].青岛大学学报(医学版),2018,54(04):458-460,464.[doi:10.11712/jms201804020]
 LI Lei,LI Meixiang,ZHANG Ying,et al.EFFICACY OF BIAPENEM IN THE TREATMENT OF CHILDREN WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA[J].JOURNAL OF QINGDAO UNIVERSITY (MEDICAL SCIENCES),2018,54(04):458-460,464.[doi:10.11712/jms201804020]
点击复制

比阿培南治疗儿童重症社区获得性肺炎效果()
分享到:

《青岛大学学报(医学版)》[ISSN:2096-5532/CN:37-1217/R]

卷:
第54卷
期数:
2018年04期
页码:
458-460,464
栏目:
出版日期:
2018-07-05

文章信息/Info

Title:
EFFICACY OF BIAPENEM IN THE TREATMENT OF CHILDREN WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA
文章编号:
2096-5532(2018)04-0458-04
作者:
李蕾李美香张颖林毅曲政海
(青岛大学附属医院儿科,山东 青岛 266003)
Author(s):
LI Lei LI Meixiang ZHANG Ying LIN Yi QU Zhenghai
(Department of Pediatrics, the Affiliated Hospital of Qingdao University Qingdao 266003, China)
关键词:
比阿培南肺炎儿童药物疗法治疗结果
Keywords:
biapenem pneumonia child drug therapy treatment outcome
分类号:
R725.63
DOI:
10.11712/jms201804020
文献标志码:
A
摘要:
目的 评价比阿培南治疗儿童重症社区获得性肺炎(CAP)的效果及安全性。
方法 以2016年1—11月间入住我院的50例重症CAP病儿为研究对象,给予比阿培南10 mg/kg每12 h静脉滴注1次,治疗时间为10~14 d。检测并比较治疗前后病儿外周血白细胞计数(WBC)、血清C反应蛋白(CRP)、降钙素原(PCT)、动脉血氧分压(PaO2)、血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、尿素氮(BUN)、肌酐(Cr)的变化,并进行临床疗效及细菌学疗效评价;观察比阿培南治疗的不良反应。
结果 总有效率为92%,其中痊愈39例,显效7例,进步3例,无效1例。病儿治疗后WBC、CRP、PCT均明显低于治疗前(t=3.52~4.07,P<0.05);PaO2明显高于治疗前(t=4.19,P<0.05);血清ALT、AST、BUN、Cr水平治疗前后比较差异无显著性(P>0.05)。24例痰液病原体检测阳性病儿的痰液细菌清除率为95.8%。所有病儿均未观察到严重不良反应。
结论 比阿培南治疗重症CAP病儿有良好的效果及较高的安全性。
Abstract:
Objective To evaluate the clinical efficacy and safety of biapenem in the treatment of children with severe community-acquired pneumonia (CAP).
Methods A total of 50 children with severe CAP who were admitted to our hospital from January to November, 2016 were taken as research subjects, and were given intravenous infusion of biapenem 10 mg/kg once every 12 h for 10-14 d. Peripheral white blood cell count (WBC), serum C-reactive protein (CRP), procalcitonin (PCT), arterial partial pressure of oxygen (PaO2), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine (Cr) of patients were determined and compared before and after the treatment; clinical efficacy and bacteriological efficacy were evaluated; adverse reactions to biapenem treatment was observed.
Results The overall response rate was 92%, including 39 cases cured, 7 cases showing marked response, 3 cases improved, and 1 case with no response. After treatment, the patients showed significant reductions in WBC count, CRP, and PTC (t=3.52-4.07,P<0.05), a significant increase in PaO2 (t=4.19,P<0.05), and no significant changes in ALT, AST, BUN, and Cr levels (P>0.05). The sputum bacterial clearance rate was 95.8% in 24 sputum pathogen-positive patients. No severe adverse reactions were observed in all 50 patients with severe CAP.
Conclusion Biapenem has good efficacy and high safety in the treatment of children with severe CAP.
更新日期/Last Update: 2018-07-08